Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.
about
Bipolar disorder: candidate drug targets.Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder.Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot studyEmerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling.Rapid cycling bipolar disorders in primary and tertiary care treated patients.Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents.Lithium to the Rescue.A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder.Targeting glutamatergic signaling for the development of novel therapeutics for mood disordersIdentification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder.Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.Efficacy of Group Cognitive-behavioral Therapy in Maintenance Treatment and Relapse Prevention for Bipolar Adolescents.
P2860
Q28751133-6E24450F-246E-4475-87DE-F984F5FA35A9Q33573983-49EAE8B6-7911-445D-8F3F-7BF12B7C29CDQ34630614-DE7E5D0C-FB63-4602-9EA0-DAA19A40C6AEQ35770190-CC469C90-0329-4984-9D75-F972783BF4ADQ36513464-9ABAC898-CF2E-4F38-B192-A33A4CCE09FEQ36532149-40884F77-E680-42E5-B555-6B3B7A2DA743Q36947163-8307ED68-BA43-4A56-B144-FE8139F14CCCQ37078843-B7EBCC7F-EC71-49D5-B7BA-72BF6C0AA79FQ37307014-C24B3C87-9FBF-42E0-935F-FA85AF2ADF5BQ37481603-E666B036-9E64-49E9-8936-9F538B71E6E6Q44736093-E4E28DD9-9CED-4120-8B3C-7B68727AE80CQ51794510-C2AA2BE5-248F-40A6-ADB8-EE1F08D91591Q54975358-D202F0D9-CDEB-48FD-8391-42F108C59A26
P2860
Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular and cellular mechani ...... ment of improved therapeutics.
@ast
Molecular and cellular mechani ...... ment of improved therapeutics.
@en
Molecular and cellular mechani ...... ment of improved therapeutics.
@nl
type
label
Molecular and cellular mechani ...... ment of improved therapeutics.
@ast
Molecular and cellular mechani ...... ment of improved therapeutics.
@en
Molecular and cellular mechani ...... ment of improved therapeutics.
@nl
prefLabel
Molecular and cellular mechani ...... ment of improved therapeutics.
@ast
Molecular and cellular mechani ...... ment of improved therapeutics.
@en
Molecular and cellular mechani ...... ment of improved therapeutics.
@nl
P2860
P356
P1433
P1476
Molecular and cellular mechani ...... ment of improved therapeutics.
@en
P2093
P2860
P2888
P356
10.1038/SJ.MP.4001068
P407
P478
P577
2002-01-01T00:00:00Z